In order to analyze changes in melanoma incidence, the authors gathered data from all 50 states and conducted age-period-cohort analyses to describe the combined impact of age, era, and cohort on incidence rates.
Publications
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy vs placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): A randomised, double-blind, placebo-controlled, phase 2 trial
Researchers conducted this randomised, double-blind, placebo-controlled, phase 2 trial to test the safety and effectiveness of adjuvant nivolumab plus ipilimumab or nivolumab monotherapy vs a placebo in patients with stage IV melanoma with no evidence of disease.
Patterns of omega-3 and omega-6 fatty acid dietary intake and melanoma thickness at diagnosis
As per experimental evidence, dietary intakes of omega-3 and omega-6 polyunsaturated fatty acids (FAs) have divergent effects on melanoma growth, researchers here sought for epidemiologic evidence on their combined effect.
Melanoma Journal Articles for Feb-April 2020
Please click on the link to see a list of melanoma journal articles that came across the MRV desk recently.